Vistagen Therapeutics Inc
(VTGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2013 | 05-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 186 | 0 | -12,887 | -9,117 | -3,782 |
| Depreciation Amortization | 106 | 0 | 289 | 373 | 83 |
| Accounts receivable | N/A | 0 | 106 | 106 | 106 |
| Other Working Capital | 580 | 0 | 1,624 | 1,128 | 1,262 |
| Other Operating Activity | -1,604 | 0 | 7,404 | 5,016 | 800 |
| Operating Cash Flow | $-732 | $0 | $-3,463 | $-2,493 | $-1,531 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | 0 | -135 | -131 | N/A |
| Investing Cash Flow | $-10 | $0 | $-135 | $-131 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 3,222 | 2,222 | 1,250 |
| Debt Repayment | -43 | 0 | -514 | -397 | -219 |
| Common Stock Issued | 236 | 0 | 1,447 | 743 | 432 |
| Financing Cash Flow | $193 | $0 | $4,156 | $2,568 | $1,463 |
| Beginning Cash Position | 638 | 0 | 81 | 81 | 81 |
| End Cash Position | 90 | 0 | 638 | 24 | 13 |
| Net Cash Flow | $-548 | $0 | $557 | $-57 | $-68 |
| Free Cash Flow | |||||
| Operating Cash Flow | -732 | 0 | -3,463 | -2,493 | -1,531 |
| Capital Expenditure | -10 | 0 | -135 | -131 | N/A |
| Free Cash Flow | -741 | 0 | -3,599 | -2,624 | -1,531 |